1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 29 SEPTEMBER 2014

CNS Drug News 29 SEPTEMBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Companion Diagnostics Could See New Alzheimer's Drugs Succeed
Industry Brief - MedGenesis/Pfizer Enter Agreement For Potential PD Treatments
Industry Trend Analysis - AstraZeneca/Lilly Deal Shares Risk Over Potential Blockbuster Alzheimer's Drug
Industry Trend Analysis - Litigation Threatens Namenda Switch Plan
Industry Brief - TauRx Achieves Enrolment Target For Second Phase III Trial Of LMTX In AD
Industry Brief - Aricept Phase III Trial In Chinese Patients With Severe AD Meets Primary Endpoint
Industry Brief - Evotec And Partners Awarded Public Grants To Develop New MS Drug Candidates
Industry Trend Analysis - Eisai Extends Aricept's Lifecycle With Japanese Approval For DLB
Industry Trend Analysis - SDP Targets Growing Cell Therapy Market With SB623 Deal
Industry Brief - NovaDel Sells ZolpiMist NDA/Licence/Intellectual Property To Amherst
Industry Brief - Lundbeck Commences European Launch Of Brintellix In Denmark
Industry Trend Analysis - Abilify Successor On Course For FDA Approval In 2015
Industry Brief - Shire Reaches Final Agreement With US Government
Industry Brief - FDA Approves Abilify Maintena Dual-Chamber Syringe
Industry Brief - PAION Grants Licence To Yichang For M6G In China
Industry Brief - Galen To Sell Penthrox In UK/Ireland
Industry Brief - Actavis Confirms Generic Butrans Patent Challenge
Industry Brief - KemPharm Receives US Patent For Novel Prodrug Of Hydromorphone
Industry Brief - Trevena Granted Key US Composition Of Matter Patent For TRV130
Industry Brief - Lannett Launches Oxycodone Oral Solution In US
Industry Brief - Milestone Triggered As Selincro Enters Market In France
Industry Trend Analysis - Novo Nordisk To Invest In Obesity Research With New Unit
Industry Brief - Edison Announces EPI-743 Phase II Results In Rett Syndrome
Industry Brief - Acorda To Acquire Civitas Therapeutics
Industry Brief - SiteOne Completes Financing Round/Secures NIH Grant
Industry Brief - Avraham Raises Funds For Ongoing Ladostigil Phase IIb Trial

Table Of Contents

CNS Drug News 29 SEPTEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.